Drug Shortage Report for NOVAHISTEX DH
| Report ID | 41428 |
| Drug Identification Number | 02049481 |
| Brand name | NOVAHISTEX DH |
| Common or Proper name | Novahistex DH 100ml |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE |
| Strength(s) | 20MG 5MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL |
| Packaging size | 100ml |
| ATC code | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-03-21 |
| Actual start date | |
| Estimated end date | 2018-05-16 |
| Actual end date | 2018-05-07 |
| Shortage status | Resolved |
| Updated date | 2018-05-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2018-05-08 | French | Compare |
| v9 | 2018-05-08 | English | Compare |
| v8 | 2018-05-07 | English | Compare |
| v7 | 2018-04-04 | French | Compare |
| v6 | 2018-04-04 | English | Compare |
| v5 | 2018-03-22 | English | Compare |
| v4 | 2018-03-15 | French | Compare |
| v3 | 2018-03-15 | English | Compare |
| v2 | 2018-03-01 | French | Compare |
| v1 | 2018-03-01 | English | Compare |
Showing 1 to 10 of 10